Key Points Interested in Surrozen, Inc.? Here are five stocks we like better. Surrozen is advancing a Wnt-based retina ...
Kalaris Therapeutics, Inc. (Nasdaq: KLRS) (“Kalaris”), a clinical-stage biopharmaceutical company dedicated to the development and commercialization of treatments for prevalent retinal diseases, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results